We have updated forecasts, mainly to reflect improved trading conditions in the Dairy market (illustrated by a stronger than expected Genus ABS performance in H2 2017) and expected R&D expenditure on the Genus PIC gene editing programme. The net result is an upgrade to FY2018-19 adj PBT of 3.9% and 5.6% respectively. Although data is limited on the PRRSv gene editing programme, it has captured the market’s imagination since the results release in September and propelled the share price above our ....
30 Oct 2017
N+1 Singer - Genus - Forecast update and upgrade to Buy
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
N+1 Singer - Genus - Forecast update and upgrade to Buy
Genus plc (GNS:LON) | 1,724 -655.1 (-2.2%) | Mkt Cap: 1,138m
- Published:
30 Oct 2017 -
Author:
Dr Jens Lindqvist -
Pages:
3
We have updated forecasts, mainly to reflect improved trading conditions in the Dairy market (illustrated by a stronger than expected Genus ABS performance in H2 2017) and expected R&D expenditure on the Genus PIC gene editing programme. The net result is an upgrade to FY2018-19 adj PBT of 3.9% and 5.6% respectively. Although data is limited on the PRRSv gene editing programme, it has captured the market’s imagination since the results release in September and propelled the share price above our ....